FDA sets new, higher bar for CAR-T cancer treatments to prove superiority

New CAR-T treatments for cancer will need to prove that they're better than existing therapies to win FDA approval, the agency's biologics chief Vinay Prasad said in a journal article Monday, raising the bar on ...